Vinpocetine 30 mg, 60 caps

Vinpocetine - support for brain and cardiovascular function

Vinpocetine is a compound studied primarily in the context of microcirculation and nerve tissue metabolism. Its effects on blood flow parameters within the brain have been reported in the literature, with interest in this compound in the area of cognitive function and concentration.

In short: what distinguishes vinpocetine?

• Investigated in the context of oxygen utilization by neural tissue.
• Described in the context of neurotransmitter balance.
• Investigated in the context of glucose utilization by nerve cells.
• Investigated in the context of cellular energy metabolism (ATP).
• May affect coagulation and platelet aggregation parameters.
• Described in the context of vascular and endothelial function.
• May be analyzed in the context of hearing comfort (e.g., tinnitus).

Vinpocetine is sometimes described as a compound that supports nerve tissue metabolism (oxygen, glucose) and processes related to cellular energy. It has also been analyzed in clinical studies in the context of cognitive function, especially in the elderly, and in the area of processes related to neurodegeneration.

In addition, the literature has described vinpocetine's effects on neurotransmitter systems (including norepinephrine and dopamine), which may translate into a subjective feeling of greater "clarity" and readiness to act in some individuals. Another mechanism described is its anti-inflammatory properties.

Due to possible effects on clotting parameters, people with blood clotting disorders and those taking anticoagulants or blood thinners should consult a doctor about vinpocetine use.

Because of the mechanism involved in vascular tone, people with blood pressure problems should exercise caution and watch their body's reaction. Its potential effect in the vascular area is sometimes described as related to the functioning of blood vessel walls.

In the literature, it is also sometimes described in the context of circulation within the auditory and visual organs.

Various dose ranges of vinpocetine have been evaluated in clinical trials, most commonly in the 5-30 mg range, depending on the study design.